In the present study, we observed that HCC patients exhibited significantly lower hepatic expression of GHR than those of cirrhosis and control groups, mostly due to hepatocellular dysfunction as a consequence of chronic liver disease, and tumor burden [54]. This evidence concerns the gene GHR and neoplasm.